The overall objective of this proposal is to seek continuing core giant support to sustain the expanding activities of the Biostatistics Shared Facility (BSF) of the Comprehensive Cancer Center (CCC). The BSF serves as a focal point from which the Center's investigators may draw statistical or epidemiologic expertise for planning, management and analysis of their studies. It also develops, tests and implements various techniques of data management and statistical analysis, including mathematical modeling, applicable to cancer research.
The specific aims of the Biostatistics Shared Facility are to: (l) coordinate and manage statistical activities in the Cancer Center to ensure that investigators have ready access to statistical consultation and support; (2) provide statistical expertise in study design including research proposal development, sample size determination and power calculation, randomization procedures, data collection form design, and plans for interim reviews and final analysis; (3) develop and manage cancer related research databases to serve as a multidisciplinary research resource for CCC investigators; (4) provide statistical analysis for CCC projects using up-to-date statistical and computing methodologies; (5) provide epidemiologic expertise in study planning and analysis for the CCC investigators, primarily in the area of cancer prevention and control research; (6) maintain a computing facility with up-to-date software for data management, statistical analysis, and network communications that is available to CCC members; (7) provide training opportunities and education in biostatistics to graduate students, oncology residents, fellows and CCC investigators regarding the applications of statistical principles to cancer research; and (8) perform statistical methodology research pertaining to practical application in cancer research. The BSF will be operated under the specific usage policies and priority guidelines established with the advice of its Advisory Committee.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA013148-28S2
Application #
6295744
Study Section
Project Start
1999-03-12
Project End
2000-02-29
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
28
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Kasten, Benjamin B; Oliver, Patsy G; Kim, Harrison et al. (2018) 212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models. Int J Mol Sci 19:
Subramaniam, Akila; Blanchard, Christina T; Erickson, Britt K et al. (2018) Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol 132:20-27
Garner, Evan F; Williams, Adele P; Stafman, Laura L et al. (2018) FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts. Sci Rep 8:6913
Stoll, Matthew L; Weiss, Pamela F; Weiss, Jennifer E et al. (2018) Age and fecal microbial strain-specific differences in patients with spondyloarthritis. Arthritis Res Ther 20:14
Locke, Landon W; Kothandaraman, Shankaran; Tweedle, Michael et al. (2018) Use of a leukocyte-targeted peptide probe as a potential tracer for imaging the tuberculosis granuloma. Tuberculosis (Edinb) 108:201-210
Fancy, Romone M; Kim, Harrison; Napier, Tiara et al. (2018) Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells. J Cell Biochem 119:6216-6230
Barrington, David A; Champion, Macie L; Boitano, Teresa K L et al. (2018) Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic. Gynecol Oncol 149:337-340
Banerjee, N Sanjib; Wang, Hsu-Kun; Beadle, James R et al. (2018) Evaluation of ODE-Bn-PMEG, an acyclic nucleoside phosphonate prodrug, as an antiviral against productive HPV infection in 3D organotypic epithelial cultures. Antiviral Res 150:164-173
Keene, Kimberly S; King, Tari; Hwang, E Shelley et al. (2018) Molecular determinants of post-mastectomy breast cancer recurrence. NPJ Breast Cancer 4:34
Kleinpeter, Alex B; Jureka, Alexander S; Falahat, Sally M et al. (2018) Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds. J Biol Chem 293:14659-14668

Showing the most recent 10 out of 747 publications